Skip to content
Home
About us
Team
Investments
Investor Relations
ESG
News
Meet us
align-justify
Menu
Home
About us
Team
Investments
Investor Relations
ESG
News
Meet us
user-group
INVESTOR ACCESS
Search
Search
Close this search box.
apps
Menu
Home
About us
Team
Investments
Investor Relations
ESG
News
Meet us
Home
/
Venture Capital
/
MRM Health Reports Preclinical...
Venture Capital
MRM Health Reports Preclinical Results Showing a 9-Strain Bacterial Consortium Delays Non-Alcoholic Fatty Liver Disease Progression and Liver Fibrosis
6 June 2022
Download
Press Release
Download
Related News
Venture Capital
Other news
November 20, 2024
Private Corner lance un feeder sur le thème de la santé avec Mérieux Equity Partners, pour son fonds Mérieux Innovation 2
arrow-up-right
Venture Capital
Other news
November 4, 2024
The Mérieux Innovation 2 fund is awarded the Tibi label, in recognition of its support to healthcare innovation in France and Europe, for the benefit of patients.
arrow-up-right
Buyout
Other news
September 19, 2024
Integrating Nature: at the heart of our “One Health” approach.
arrow-up-right
